Life sciences industry insights with Tecan

This video explores Tecan’s role in advancing automation, AI-driven drug discovery, and multi-omics solutions in the life sciences industry. Mukta Acharya and Remi Megnan discuss the growing demand for flexible, high-throughput instrumentation, the integration of AI, and the emerging trends in automation across genomics, proteomics, and chemistry labs.

With the rise of multi-omics approaches, automation vendors must streamline workflows, integrate third-party solutions, and address regulatory challenges. Tecan’s latest solutions, like Veya, aim to tackle these evolving needs, helping researchers increase efficiency, accuracy, and scalability in life sciences applications.

Run time: 5.09min

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.